Press Releases
Feb. 12, 2026
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
Feb. 12, 2026
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
Indeterminate
GlobeNewswire, Inc.
Feb. 1, 2026
Jeffrey L. Carrier releases Depression-Era Trilogy of Fiction, Coal Dust on Purple Asters
Neutral
EIN Presswire
Jan. 30, 2026
Obsidian Sky Ignites A New Fantasy Realm Of Elemental Magic, Dragon-Riders, And Forbidden Destiny
Neutral
EIN Presswire
Feb. 12, 2026
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
Feb. 4, 2026
The Day After His Crucifixion Gives Voice To The Women Who Walked With Yeshua
Neutral
EIN Presswire
Feb. 12, 2026
Top Coated PET Film Suppliers in China: Key Industry Players and Market Insights
Neutral
EIN Presswire
Feb. 12, 2026
Top AI Safety Expert Resigns with Enigmatic 'Peril' Warning
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Feb. 11, 2026
Measure, Model, Tackle, Tailor: The Bank of England’s approach to assessing and managing climate impacts across its core objectives - speech by James Talbot
Gov't Institution
Bank of England
Owner: British Government
Feb. 12, 2026
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
Indeterminate
GlobeNewswire, Inc.
Feb. 3, 2026
Captivating Saga Expiates 1960s Mississippi Newspaper Influence
Neutral
EIN Presswire
Jan. 26, 2026
Alan Collenette Releases 'Love Brain and Other Minefields', a Bold Exploration of Love, Loss, and Connection
Neutral
EIN Presswire
Feb. 11, 2026
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Generative AI A Game Changer in Healthcare
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
RNA Analysis Market Size Worth USD 23.39 Billion by 2035 Fueled by Expansion of RNA Therapeutics and Precision Medicine
Indeterminate
GlobeNewswire, Inc.